Search results
Smart Money Is Betting Big In BMY Options - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 7 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb . Looking at options history for Bristol-Myers Squibb BMY we detected ...
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
The New York Times via Yahoo News· 2 hours agoAmericans are paying too much for prescription drugs. It is a common, long-standing complaint. And...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 6 days agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade |...
The Motley Fool· 6 days agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 7 days agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
New York Times· 2 hours agoPharmacy benefit managers are driving up drug costs for millions of people, employers and the...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 7 days agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
Amicus Therapeutics opens global HQ in Princeton
NJBIZ· 3 hours agoAmicus Therapeutics cut the ribbon last week on a sparkling new global headquarters located on Hulfish Street in Princeton. Founded by John Crowley in...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 2 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Why Wall Street Is Chasing Ozempic Wannabes
The Wall Street Journal· 18 hours agoHEARD ON THE STREET Gilead Sciences a biotech company focused on treatments for cancer and HIV, isn’t pitching itself as an obesity-drug developer. But...